Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The knowns and unknowns of teprotumumab for thyroid eye disease.

Literature DB >> 33865499

The knowns and unknowns of teprotumumab for thyroid eye disease.

Tomasz Bednarczuk¹, Simon H Pearce².

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2021 PMID： 33865499 DOI： 10.1016/S2213-8587(21)00076-0

Source DB: PubMed Journal: Lancet Diabetes Endocrinol ISSN： 2213-8587 Impact factor: 32.069

Keyword Cloud
Cited

× No keyword cloud information.

1 in total

1. TSH receptor specific monoclonal autoantibody K1-70^TM targeting of the TSH receptor in subjects with Graves' disease and Graves' orbitopathy-Results from a phase I clinical trial.

Authors: Jadwiga Furmaniak; Jane Sanders; Paul Sanders; Yang Li; Bernard Rees Smith
Journal: Clin Endocrinol (Oxf) Date: 2022-02-06 Impact factor: 3.523

1 in total

The knowns and unknowns of teprotumumab for thyroid eye disease.

1. TSH receptor specific monoclonal autoantibody K1-70TM targeting of the TSH receptor in subjects with Graves' disease and Graves' orbitopathy-Results from a phase I clinical trial.

1. TSH receptor specific monoclonal autoantibody K1-70^TM targeting of the TSH receptor in subjects with Graves' disease and Graves' orbitopathy-Results from a phase I clinical trial.